{"gene":"RGS3","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":1997,"finding":"A truncated C-terminal form of RGS3 (RGS3T) inhibits Gq-mediated inositol phosphate production and Gs-mediated cAMP production in intact cells, while both full-length RGS3 and RGS3T impair Gi-mediated ERK1/2 phosphorylation, demonstrating that the C-terminal RGS domain is sufficient for Gq/Gs inhibition and that both forms regulate Gi signaling.","method":"Transient transfection of BHK cells with RGS3 or RGS3T cDNA followed by inositol phosphate, cAMP, and ERK phosphorylation assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional assays in intact cells with defined receptor-specific readouts, single lab, multiple signaling endpoints","pmids":["9182581"],"is_preprint":false},{"year":1997,"finding":"RGS3 binds Gq-alpha protein in vitro; recombinant RGS3-GST fusion protein bound ~5-fold more 35S-labeled Gqα than GST alone, and RGS3 expression suppressed GnRH-stimulated IP3 responses by 75% in COS-1 cells, identifying Gqα as the mechanistic target mediating GnRH desensitization.","method":"GST pulldown with 35S-met labeled Gqα; co-transfection of GnRH receptor and RGS3 in COS-1 cells with IP3 measurement","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — GST pulldown plus functional assay in intact cells, single lab, two orthogonal methods","pmids":["9003025"],"is_preprint":false},{"year":1999,"finding":"RGS3 inhibits G protein-coupled receptor signaling by translocating from the cytosol to the plasma membrane upon G protein activation; this translocation is mediated by a dual mechanism involving both the C-terminal RGS domain (which binds activated Gα11-QL constitutively) and the N-terminal domain (which translocates in response to agonist stimulation via a calcium-dependent mechanism). RGS3 co-immunoprecipitates with AlF4-activated Gα11 and, to a lesser extent, Gαi3, through its RGS domain.","method":"Co-immunoprecipitation of RGS3 with activated Gα subunits; Western blotting of cytosolic and particulate fractions; immunofluorescence microscopy; calcium ionophore experiments; deletion mutant analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (co-IP, subcellular fractionation, immunofluorescence, mutant constructs) in single rigorous study","pmids":["9858594"],"is_preprint":false},{"year":2000,"finding":"RGS3 functions as a GTPase-activating protein (GAP) for Gαi (except Gαz) and Gαq subunits but not Gαs or Gα12, with Gαq GAP activity comparable to RGS4. Mutation of residues in the RGS domain analogous to those required for RGS4 Gαi GAP activity impaired RGS3 function. RGS3 also acts as a potent Gαq effector antagonist blocking PLC-β activation, an activity that distinguishes it from RGS4.","method":"In vitro GTPase assay; active-site mutagenesis; reporter gene assay (CREB); inositol phosphate production assay in intact cells","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro GTPase reconstitution combined with active-site mutagenesis and multiple functional assays","pmids":["10999941"],"is_preprint":false},{"year":2001,"finding":"RGS3 directly binds Gβ1γ2 subunits and inhibits Gβγ-mediated signaling (inositol phosphate production, Akt activation, and MAPK activation) independently of its GAP activity; inhibition requires two regions (residues 313–390 and 391–458) outside the RGS domain. RGS3 also inhibits Gβγ-mediated PLC-β activation in vitro.","method":"Co-expression of RGS3 with Gβ1γ2 in COS-7 and HEK293 cells; deletion mutant analysis; in vitro PLC-β activation assay; inositol phosphate and Akt/MAPK assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of Gβγ-PLC inhibition plus domain mapping by deletion mutagenesis plus multiple cellular signaling readouts","pmids":["11294858"],"is_preprint":false},{"year":2001,"finding":"Adenoviral-mediated RGS3 gene transfer in rat pituitary gonadotropes inhibits GnRH-stimulated LH secretion in a dose-dependent manner, consistent with RGS3 acting at Gqα to suppress inositol phosphate accumulation and downstream LH release.","method":"Adenoviral transduction of rat pituitary cells; LH secretion assay; 3H-inositol phosphate accumulation assay","journal":"BMC cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct gene delivery to primary cells with defined functional readout, single lab, two endpoints","pmids":["11716781"],"is_preprint":false},{"year":2002,"finding":"RGS3 interacts with 14-3-3 protein via a single binding site at Ser264 in its N-terminal region (outside the RGS domain); the S264A mutation abolishes 14-3-3 binding without affecting Gαq binding. 14-3-3-bound RGS3 cannot interact with G proteins, so 14-3-3 acts as a negative regulator of RGS3 by sequestering it away from Gα subunits. The S264A mutant is more potent than wild-type RGS3 in inhibiting G protein signaling.","method":"Yeast two-hybrid screening; in vitro binding assays; co-immunoprecipitation; site-directed mutagenesis (S264A); signaling assays","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — yeast two-hybrid plus in vitro binding plus co-IP plus mutagenesis plus functional signaling assays in one study","pmids":["11985497"],"is_preprint":false},{"year":2002,"finding":"Endogenous RGS3 specifically negatively modulates muscarinic m3 receptor (carbachol)-stimulated MAP kinase activity through Gq/11 (pertussis toxin-insensitive) in rat vascular smooth muscle cells, as demonstrated by ribozyme-mediated knockdown of RGS3 but not RGS2, RGS5, or RGS7.","method":"Synthetic ribozymes targeting RGS3 transfected into rat aorta smooth muscle cells; MAP kinase activation assay; pertussis toxin treatment","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ribozyme knockdown with receptor-selective readout, single lab, pertussis toxin control","pmids":["12006602"],"is_preprint":false},{"year":2002,"finding":"RGS3 undergoes agonist-dependent palmitoylation: palmitic acid incorporation into RGS3 is dependent on agonist occupancy of the GnRH receptor, whereas RGS10 palmitoylation is constitutive. This ligand-regulated palmitoylation represents a novel post-translational regulatory mechanism for RGS3.","method":"Overexpression in GGH3 cells with palmitic acid incorporation assay; site-directed mutagenesis of palmitoylation site in RGS10 as comparison","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct biochemical palmitoylation assay with agonist dependence, single lab","pmids":["11897687"],"is_preprint":false},{"year":2003,"finding":"RGS3 mediates calcium-dependent rapid termination of G protein (Go) signaling in dorsal root ganglion neurons; calcium influx through voltage-gated channels directly binds to an EF-hand domain of RGS3. Deletion of the EF-hand domain abolishes both the calcium-RGS3 interaction (gel-shift assay) and the rapid desensitization of Go-mediated N-type Ca2+ channel inhibition. A naturally occurring RGS3 variant lacking the EF hand produces slower, calmodulin-dependent desensitization instead.","method":"Retroviral overexpression of RGS3 isoforms and EF-hand deletion mutants in dorsal root ganglion neurons; electrophysiological recording of N-type Ca2+ channel inhibition; gel-shift calcium-binding assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — EF-hand deletion mutagenesis combined with biochemical calcium binding assay and electrophysiological functional readout in native neurons","pmids":["12771384"],"is_preprint":false},{"year":2004,"finding":"RGS3 (short isoform RGS3s) does not interact with GPCR-Kir3 channel complexes, in contrast to RGS4. RGS3s modulates m2 receptor-coupled GIRK channels by 'collision coupling' rather than 'precoupling', reducing maximal ACh-evoked GIRK current amplitude ~45% and shifting the dose-response relation, while RGS4 precouples to the receptor complex with ~100-fold greater potency in accelerating Kir3 channel-gating kinetics.","method":"Co-immunoprecipitation of RGS constructs with GPCR-Kir3 complexes in CHO-K1 cells; deletion and chimeric RGS constructs; electrophysiological recording of GIRK channel gating kinetics","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus electrophysiology plus chimeric constructs, single lab, mechanistically informative negative result for RGS3s-GPCR interaction","pmids":["16973624"],"is_preprint":false},{"year":2006,"finding":"Full-length RGS3 and its native isoform RGS3T antagonize muscarinic M2 receptor-mediated inhibition of Cav2.3 (R-type) Ca2+ channels equally effectively; the core RGS domain alone is sufficient for this activity and the extended N-terminal domain does not enhance signaling function. The N-terminal domain of RGS3 restricts its localization to the cytoplasm as shown by confocal microscopy of GFP fusion proteins.","method":"Whole-cell patch-clamp recordings in HEK293 cells expressing Cav2.3, M2R, and RGS3 deletion mutants; confocal microscopy of RGS3-EGFP fusion proteins","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — electrophysiology with deletion mutants plus direct imaging of subcellular localization, single lab","pmids":["16855219"],"is_preprint":false},{"year":2008,"finding":"RGS3 interacts with Smad2, Smad3, and Smad4 via a region outside its RGS domain binding to the Smad MH2 domain. RGS3 overexpression inhibits TGF-β-induced Smad-mediated gene transcription by preventing Smad3-Smad4 heteromerization without affecting TGF-β-induced Smad phosphorylation, and inhibits TGF-β-induced myofibroblast differentiation.","method":"Co-immunoprecipitation of RGS3 with Smad proteins; domain mapping; reporter gene transcription assay; Smad heteromerization assay; myofibroblast differentiation assay","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus domain mapping plus multiple functional readouts, single lab","pmids":["18287247"],"is_preprint":false},{"year":2010,"finding":"14-3-3 protein binding induces structural changes in both the N-terminal region and the C-terminal RGS domain of phosphorylated RGS3, affecting the Gα-interacting portion of the RGS domain. The crystal structure of the RGS domain of RGS3 was solved at 2.3 Å resolution. The isolated RGS domain can interact with 14-3-3 in a phosphorylation-independent manner.","method":"Time-resolved tryptophan fluorescence spectroscopy with single-tryptophan mutants; X-ray crystallography of RGS domain at 2.3 Å resolution","journal":"Journal of structural biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure determination plus fluorescence spectroscopy with mutagenesis, single lab, two orthogonal structural methods","pmids":["20347994"],"is_preprint":false},{"year":2010,"finding":"Knockout of PDZ-RGS3 in mice causes early cell cycle exit and precocious differentiation of neural progenitor cells in the developing cerebral cortex, resulting in loss of cortical neural progenitor cells and impaired production of late-born cortical neurons, phenocopying ephrin-B1 knockout, thereby placing PDZ-RGS3 downstream of ephrin-B reverse signaling in neural progenitor maintenance.","method":"Genetic knockout (PDZ-RGS3 null mice); cortical neurogenesis analysis; comparison with ephrin-B1 knockout phenotype; cell cycle analysis","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with defined cellular phenotype and epistasis placement downstream of ephrin-B reverse signaling pathway","pmids":["20629178"],"is_preprint":false},{"year":2011,"finding":"The 14-3-3ζ protein forms a complex with RGS3 in which the RGS domain of RGS3 binds to the outer surface of the 14-3-3ζ dimer (outside its central channel), and this binding both sterically occludes the Gα interaction surface of the RGS domain and induces conformational changes that impair its Gα binding.","method":"Small angle X-ray scattering (SAXS); hydrogen/deuterium exchange kinetics; FRET measurements; low-resolution solution structure determination","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — SAXS structure plus H/D exchange plus FRET, three orthogonal structural/biophysical methods in single study","pmids":["22027839"],"is_preprint":false},{"year":2012,"finding":"PDZ-RGS3 (isoform 1) is upregulated by Wnt signaling, binds GSK3β, and decreases GSK3β catalytic activity toward β-catenin, thereby enhancing canonical Wnt/β-catenin signaling. PDZ-RGS3 overexpression enhances Snail1 expression and promotes epithelial-mesenchymal transition (EMT).","method":"Co-immunoprecipitation of PDZ-RGS3 with GSK3β; kinase activity assay for GSK3β toward β-catenin; β-catenin reporter assay; Wnt3a stimulation; EMT morphological and biochemical analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus kinase activity assay plus reporter assay, single lab, multiple functional endpoints","pmids":["22859293"],"is_preprint":false},{"year":2013,"finding":"Endogenous RGS3 controls T cell migration in a non-redundant manner; mice with RGS domain deletion (RGS3ΔRGS) show increased T cell numbers and formation of perivascular lymphoid structures in the lung in an asthma model, with reduced T cell numbers in draining lymph nodes, demonstrating RGS3 restricts T cell migration via its G protein regulatory (RGS) domain.","method":"Generation of RGS3ΔRGS knock-in mice; experimental asthma model; T cell enumeration in lungs and draining lymph nodes; in vitro T cell migration assay with RGS3-knockdown thymoma cells","journal":"American journal of physiology. Lung cellular and molecular physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — domain-specific knock-in mouse model with in vivo and in vitro evidence for T cell migration control, multiple readouts","pmids":["24077945"],"is_preprint":false},{"year":2021,"finding":"RGS3, previously known only as a regulator of GPCR/G protein signaling, can also directly enhance the GTPase activity of both wild-type and mutant KRAS proteins (including KRASG12C), thereby inactivating KRAS and enabling KRASG12C inhibitor efficacy by promoting GTP hydrolysis and accumulation of the GDP-bound inactive state.","method":"GTPase activity assays with recombinant RGS3 and KRAS proteins; biochemical and cellular studies of KRAS inactivation; KRASG12C inhibitor sensitivity experiments","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of GTPase-activating activity on KRAS with multiple mutants, combined with cellular mechanistic validation","pmids":["34618566"],"is_preprint":false},{"year":2020,"finding":"RGS3 interacts with KIF20A and together they regulate the balance between proliferative and differentiative divisions of neural progenitor cells in the developing cortex independently of spindle/cleavage plane orientation, revealing a spindle orientation-independent mechanism of cell fate determination.","method":"Loss-of-function genetic experiments in mice (RGS3 and KIF20A inactivation); spindle orientation measurement; neural progenitor cell fate analysis","journal":"Cerebral cortex communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined cellular phenotype and epistasis between RGS3 and KIF20A, single lab","pmids":["32864611"],"is_preprint":false},{"year":2004,"finding":"Single phosphorylation of Tyr304 on ephrin-B2 enables bifunctional binding to both the SH2 domain of Grb4 and the PDZ domain of PDZ-RGS3 simultaneously, forming a three-component molecular complex, as determined by NMR HSQC experiments and binding assays.","method":"NMR (1H-15N HSQC) binding experiments; in vitro binding assays with phosphopeptides; three-component complex reconstitution","journal":"European journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — NMR structural validation of interaction plus reconstitution of ternary complex, single lab","pmids":["15096211"],"is_preprint":false},{"year":2025,"finding":"RGS3 directly interacts with ARID3B and facilitates phosphorylation of SMAD2/3, thereby enhancing TGF-β pathway activity and driving ovarian cancer cell proliferation and metastasis through EMT. Silencing RGS3 promotes apoptosis and inhibits tumor growth in ovarian cancer cells.","method":"Co-immunoprecipitation of RGS3 with ARID3B; SMAD2/3 phosphorylation assay; siRNA knockdown with proliferation, apoptosis, and metastasis readouts","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus phosphorylation assay plus functional knockdown, single lab","pmids":["40456746"],"is_preprint":false}],"current_model":"RGS3 is a multi-isoform RGS family protein that functions primarily as a GTPase-activating protein (GAP) for Gαi and Gαq (but not Gαs, Gαz, or Gα12) subunits, accelerating GTP hydrolysis to terminate GPCR signaling; it also directly binds Gβγ subunits to block their effector interactions, translocates from cytosol to plasma membrane upon G protein activation via both its RGS and N-terminal domains, undergoes agonist-dependent palmitoylation and phosphorylation-dependent sequestration by 14-3-3 (which induces conformational changes in the RGS domain to sterically block Gα binding), binds calcium via an EF-hand domain to mediate rapid desensitization of Go signaling in sensory neurons, interacts with Smad2/3/4 to inhibit TGF-β transcriptional responses, and — through its PDZ-RGS3 isoform — links ephrin-B reverse signaling to neural progenitor self-renewal and modulates canonical Wnt signaling by binding and inhibiting GSK3β; additionally, RGS3 unexpectedly enhances GTPase activity of both wild-type and mutant KRAS, revealing a non-GPCR substrate."},"narrative":{"mechanistic_narrative":"RGS3 is a multi-isoform regulator of G protein signaling that terminates GPCR cascades by acting as a GTPase-activating protein (GAP) for Gαi (excluding Gαz) and Gαq, accelerating GTP hydrolysis, while sparing Gαs and Gα12 [PMID:10999941]. Beyond its catalytic GAP function, RGS3 antagonizes Gαq-driven PLC-β activation as an effector antagonist [PMID:10999941] and independently binds Gβ1γ2 through regions outside the RGS domain to block Gβγ-mediated inositol phosphate, Akt, and MAPK signaling [PMID:11294858]. RGS3 controls signaling at endogenous receptors, negatively modulating Gq/11-coupled muscarinic m3 responses in vascular smooth muscle [PMID:12006602] and Gq-coupled GnRH receptor desensitization that suppresses LH secretion [PMID:9003025, PMID:11716781]. Its activity is spatially and post-translationally tuned: it translocates from cytosol to plasma membrane upon G protein activation via both RGS and N-terminal domains [PMID:9858594], undergoes agonist-dependent palmitoylation [PMID:11897687], and is sequestered by 14-3-3 binding at Ser264, which both sterically occludes and conformationally distorts the Gα-interaction surface of the RGS domain [PMID:11985497, PMID:20347994, PMID:22027839]. In sensory neurons, an EF-hand-containing isoform binds calcium entering through voltage-gated channels to drive rapid, calcium-dependent desensitization of Go-mediated N-type Ca2+ channel inhibition [PMID:12771384]. RGS3 also operates outside canonical G protein biology: it binds Smad2/3/4 to block Smad heteromerization and inhibit TGF-β transcription [PMID:18287247], and through its PDZ-RGS3 isoform links phospho-ephrin-B reverse signaling to neural progenitor self-renewal [PMID:20629178, PMID:15096211] and enhances canonical Wnt/β-catenin signaling by binding and inhibiting GSK3β [PMID:22859293]. Most unexpectedly, RGS3 directly enhances GTPase activity of wild-type and mutant KRAS, including KRASG12C, promoting its inactive GDP-bound state [PMID:34618566].","teleology":[{"year":1997,"claim":"Established the founding question of which G protein classes RGS3 acts on, showing isoform-specific suppression of Gq, Gs, and Gi signaling and that the C-terminal RGS domain carries the inhibitory function.","evidence":"Transfection of RGS3/RGS3T into BHK and COS-1 cells with IP, cAMP, ERK, and IP3 readouts plus GST pulldown of Gqα","pmids":["9182581","9003025"],"confidence":"Medium","gaps":["Cellular assays did not distinguish GAP catalysis from effector antagonism","No in vitro GTPase reconstitution at this stage"]},{"year":1999,"claim":"Resolved how RGS3 reaches its target, demonstrating activation-dependent cytosol-to-membrane translocation driven by both the RGS and N-terminal domains.","evidence":"Co-IP with AlF4-activated Gα subunits, subcellular fractionation, immunofluorescence, and deletion mutants","pmids":["9858594"],"confidence":"High","gaps":["Calcium-dependent N-terminal translocation mechanism not molecularly defined here","Endogenous translocation dynamics not measured"]},{"year":2000,"claim":"Defined RGS3 biochemically as a bona fide GAP for Gαi/Gαq with active-site residues homologous to RGS4, and uncovered a distinct Gαq effector-antagonist activity.","evidence":"In vitro GTPase assays, active-site mutagenesis, CREB reporter, and IP production assays","pmids":["10999941"],"confidence":"High","gaps":["Structural basis of effector antagonism not resolved","Selectivity rules against Gαz/Gαs/Gα12 not mechanistically explained"]},{"year":2001,"claim":"Extended RGS3 function beyond GAP activity by showing direct Gβγ binding and inhibition of Gβγ effector signaling through domains outside the RGS module.","evidence":"Co-expression with Gβ1γ2 in COS-7/HEK293, deletion mapping, in vitro PLC-β assay, and Akt/MAPK readouts","pmids":["11294858"],"confidence":"High","gaps":["Structure of the RGS3-Gβγ complex unknown","Physiological contribution of Gβγ inhibition versus GAP activity not dissected"]},{"year":2002,"claim":"Identified post-translational and regulatory control of RGS3 — 14-3-3 sequestration at Ser264 and agonist-dependent palmitoylation — and confirmed non-redundant control of endogenous Gq/11 muscarinic signaling.","evidence":"Yeast two-hybrid, in vitro binding, co-IP, S264A mutagenesis, palmitate incorporation assays, and ribozyme knockdown in vascular smooth muscle","pmids":["11985497","11897687","12006602"],"confidence":"High","gaps":["Kinase responsible for Ser264 phosphorylation not identified","Palmitoylation site and enzyme not mapped","Functional interplay between palmitoylation and 14-3-3 sequestration unresolved"]},{"year":2003,"claim":"Revealed a calcium-sensing function: an EF-hand isoform of RGS3 binds calcium entering through voltage-gated channels to mediate rapid feedback desensitization of Go signaling in neurons.","evidence":"Retroviral isoform/EF-hand-deletion expression in DRG neurons, electrophysiology of N-type Ca2+ channels, and gel-shift calcium binding","pmids":["12771384"],"confidence":"High","gaps":["Structural detail of EF-hand calcium coordination not determined","Whether EF-hand isoform contributes to other GPCR pathways unknown"]},{"year":2004,"claim":"Mechanistically detailed PDZ-RGS3 recruitment to ephrin-B reverse signaling, showing a single ephrin-B2 phosphotyrosine enables simultaneous Grb4 and PDZ-RGS3 binding.","evidence":"NMR HSQC binding experiments, phosphopeptide binding assays, and three-component complex reconstitution","pmids":["15096211"],"confidence":"Medium","gaps":["Downstream signaling output of the ternary complex not defined here","In vivo relevance established only later"]},{"year":2006,"claim":"Refined isoform/domain logic in channel modulation, showing the short RGS3 isoform regulates GIRK channels by collision rather than precoupling and that the N-terminal domain restricts cytoplasmic localization.","evidence":"Co-IP and electrophysiology of GPCR-Kir3/Cav2.3 complexes in CHO-K1/HEK293 with chimeric and deletion constructs and EGFP imaging","pmids":["16973624","16855219"],"confidence":"Medium","gaps":["Quantitative kinetic comparison limited to specific channel/receptor pairs","Structural basis for collision versus precoupling not established"]},{"year":2008,"claim":"Connected RGS3 to TGF-β signaling, demonstrating a non-RGS region binds the Smad MH2 domain to block Smad3-Smad4 heteromerization and inhibit transcription independent of receptor phosphorylation.","evidence":"Co-IP, domain mapping, Smad reporter and heteromerization assays, and myofibroblast differentiation assay","pmids":["18287247"],"confidence":"Medium","gaps":["Single-lab finding without reciprocal in vivo validation","Reconciliation with later report of RGS3 enhancing SMAD2/3 phosphorylation unaddressed"]},{"year":2010,"claim":"Provided structural mechanism for 14-3-3 inhibition and an in vivo role for PDZ-RGS3, solving the RGS domain crystal structure and showing 14-3-3 binding distorts the Gα-interaction surface, while PDZ-RGS3 knockout phenocopies ephrin-B1 loss in cortical neurogenesis.","evidence":"X-ray crystallography at 2.3 Å, time-resolved tryptophan fluorescence with single-Trp mutants, and PDZ-RGS3 knockout mouse neurogenesis analysis","pmids":["20347994","20629178"],"confidence":"High","gaps":["Full-length RGS3 structure not solved","Molecular signaling linking PDZ-RGS3 to progenitor cell cycle not fully defined"]},{"year":2011,"claim":"Completed the structural model of 14-3-3 regulation, showing the RGS domain docks on the outer surface of the 14-3-3ζ dimer to both occlude and conformationally impair Gα binding.","evidence":"SAXS solution structure, H/D exchange kinetics, and FRET","pmids":["22027839"],"confidence":"High","gaps":["Atomic-resolution structure of the complex not obtained","Cellular stoichiometry of 14-3-3-RGS3 regulation unmeasured"]},{"year":2012,"claim":"Linked PDZ-RGS3 to canonical Wnt signaling and EMT, showing Wnt-induced PDZ-RGS3 binds and inhibits GSK3β to stabilize β-catenin and promote Snail1-driven EMT.","evidence":"Co-IP, GSK3β kinase activity assay, β-catenin reporter, Wnt3a stimulation, and EMT analysis","pmids":["22859293"],"confidence":"Medium","gaps":["Single-lab study without in vivo confirmation","Mechanism of GSK3β inhibition (direct versus complex-mediated) not resolved"]},{"year":2013,"claim":"Demonstrated a non-redundant in vivo immune function, with RGS-domain deletion increasing T cell accumulation in lung and altering migration, establishing RGS3's GAP function in restricting T cell trafficking.","evidence":"RGS3ΔRGS knock-in mice in an asthma model, T cell enumeration, and in vitro migration with RGS3-knockdown thymoma cells","pmids":["24077945"],"confidence":"High","gaps":["Specific chemokine receptors/Gα targets in T cells not identified","Cell-intrinsic versus extrinsic effects not fully separated"]},{"year":2020,"claim":"Identified a spindle-orientation-independent mode of progenitor fate control, with RGS3 partnering KIF20A to balance proliferative versus differentiative divisions.","evidence":"Loss-of-function genetics in mice, spindle orientation measurement, and progenitor fate analysis","pmids":["32864611"],"confidence":"Medium","gaps":["Biochemical nature of the RGS3-KIF20A interaction undefined","Molecular pathway downstream of the pairing unresolved"]},{"year":2021,"claim":"Overturned the GPCR-exclusive view of RGS3 by showing it directly acts as a GAP for KRAS, including KRASG12C, promoting GDP-bound inactivation and enabling inhibitor efficacy.","evidence":"In vitro GTPase assays with recombinant RGS3 and KRAS mutants plus cellular KRASG12C inhibitor sensitivity experiments","pmids":["34618566"],"confidence":"High","gaps":["Structural basis of RGS3 engagement of KRAS not determined","Selectivity over other small GTPases unexplored"]},{"year":2025,"claim":"Implicated RGS3 in ovarian cancer, showing it binds ARID3B and promotes SMAD2/3 phosphorylation to drive TGF-β-dependent proliferation and metastasis.","evidence":"Co-IP with ARID3B, SMAD2/3 phosphorylation assays, and siRNA knockdown with proliferation, apoptosis, and metastasis readouts","pmids":["40456746"],"confidence":"Medium","gaps":["Single-lab finding without reciprocal validation","Apparent contradiction with earlier inhibition of Smad signaling (#12) not reconciled","Direct ARID3B-RGS3 binding interface unmapped"]},{"year":null,"claim":"It remains unresolved how RGS3's diverse activities — GAP toward Gα and KRAS, Gβγ binding, Smad and GSK3β regulation — are partitioned across its isoforms and integrated in a single cell context.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified isoform-resolved map of which domains/isoforms execute each function","Opposite effects on TGF-β/Smad signaling across studies unreconciled","No full-length structure to relate domains spatially"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,4,18]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[3,18]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[4]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[2,3]},{"term_id":"GO:0140299","term_label":"molecular sensor activity","supporting_discovery_ids":[9]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2,11]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,4,7]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[14,19,20]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[17]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[18,21]}],"complexes":[],"partners":["GNAQ","GNAI3","GNB1","YWHAZ","SMAD3","SMAD4","GSK3B","KRAS"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P49796","full_name":"Regulator of G-protein signaling 3","aliases":[],"length_aa":1198,"mass_kda":132.3,"function":"Down-regulates signaling from heterotrimeric G-proteins by increasing the GTPase activity of the alpha subunits, thereby driving them into their inactive GDP-bound form. Down-regulates G-protein-mediated release of inositol phosphates and activation of MAP kinases","subcellular_location":"Cytoplasm; Nucleus; Cell membrane","url":"https://www.uniprot.org/uniprotkb/P49796/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RGS3","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RGS3","total_profiled":1310},"omim":[{"mim_id":"605072","title":"GIPC PDZ DOMAIN-CONTAINING FAMILY, MEMBER 1; GIPC1","url":"https://www.omim.org/entry/605072"},{"mim_id":"602189","title":"REGULATOR OF G PROTEIN SIGNALING 3; RGS3","url":"https://www.omim.org/entry/602189"},{"mim_id":"600835","title":"CHEMOKINE, CXC MOTIF, LIGAND 12; CXCL12","url":"https://www.omim.org/entry/600835"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"choroid plexus","ntpm":142.2}],"url":"https://www.proteinatlas.org/search/RGS3"},"hgnc":{"alias_symbol":["C2PA","FLJ20370","PDZ-RGS3"],"prev_symbol":[]},"alphafold":{"accession":"P49796","domains":[{"cath_id":"2.60.40.150","chopping":"136-271","consensus_level":"high","plddt":87.1781,"start":136,"end":271},{"cath_id":"2.30.42.10","chopping":"297-376","consensus_level":"high","plddt":90.011,"start":297,"end":376},{"cath_id":"2.30.29.30","chopping":"563-672","consensus_level":"high","plddt":81.3465,"start":563,"end":672},{"cath_id":"1.10.167.10","chopping":"1065-1191","consensus_level":"high","plddt":93.2005,"start":1065,"end":1191}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P49796","model_url":"https://alphafold.ebi.ac.uk/files/AF-P49796-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P49796-F1-predicted_aligned_error_v6.png","plddt_mean":54.97},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RGS3","jax_strain_url":"https://www.jax.org/strain/search?query=RGS3"},"sequence":{"accession":"P49796","fasta_url":"https://rest.uniprot.org/uniprotkb/P49796.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P49796/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P49796"}},"corpus_meta":[{"pmid":"9182581","id":"PMC_9182581","title":"A truncated form of RGS3 negatively regulates G protein-coupled receptor stimulation of adenylyl cyclase and phosphoinositide phospholipase C.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9182581","citation_count":110,"is_preprint":false},{"pmid":"12006602","id":"PMC_12006602","title":"Receptor-selective effects of endogenous RGS3 and RGS5 to regulate mitogen-activated protein kinase activation in rat vascular smooth muscle cells.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12006602","citation_count":99,"is_preprint":false},{"pmid":"9858594","id":"PMC_9858594","title":"RGS3 inhibits G protein-mediated signaling via translocation to the membrane and binding to Galpha11.","date":"1999","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9858594","citation_count":97,"is_preprint":false},{"pmid":"9003025","id":"PMC_9003025","title":"Potential role for a regulator of G protein signaling (RGS3) in gonadotropin-releasing hormone (GnRH) stimulated desensitization.","date":"1997","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9003025","citation_count":91,"is_preprint":false},{"pmid":"10999941","id":"PMC_10999941","title":"RGS3 is a GTPase-activating protein for g(ialpha) and g(qalpha) and a potent inhibitor of signaling by GTPase-deficient forms of g(qalpha) and g(11alpha).","date":"2000","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10999941","citation_count":73,"is_preprint":false},{"pmid":"34618566","id":"PMC_34618566","title":"The G protein signaling regulator RGS3 enhances the GTPase activity of KRAS.","date":"2021","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/34618566","citation_count":70,"is_preprint":false},{"pmid":"16821082","id":"PMC_16821082","title":"Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers.","date":"2006","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/16821082","citation_count":69,"is_preprint":false},{"pmid":"15055445","id":"PMC_15055445","title":"Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility.","date":"2004","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15055445","citation_count":64,"is_preprint":false},{"pmid":"11428836","id":"PMC_11428836","title":"Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure.","date":"2001","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/11428836","citation_count":63,"is_preprint":false},{"pmid":"9515003","id":"PMC_9515003","title":"RGS3 and RGS4 are GTPase activating proteins in the heart.","date":"1998","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/9515003","citation_count":61,"is_preprint":false},{"pmid":"17196529","id":"PMC_17196529","title":"C. elegans G protein regulator RGS-3 controls sensitivity to sensory stimuli.","date":"2007","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/17196529","citation_count":55,"is_preprint":false},{"pmid":"16973624","id":"PMC_16973624","title":"RGS3 and RGS4 differentially associate with G protein-coupled receptor-Kir3 channel signaling complexes revealing two modes of RGS modulation. Precoupling and collision coupling.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16973624","citation_count":44,"is_preprint":false},{"pmid":"11294858","id":"PMC_11294858","title":"Regulator of G-protein signaling 3 (RGS3) inhibits Gbeta1gamma 2-induced inositol phosphate production, mitogen-activated protein kinase activation, and Akt activation.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11294858","citation_count":43,"is_preprint":false},{"pmid":"11985497","id":"PMC_11985497","title":"RGS3 interacts with 14-3-3 via the N-terminal region distinct from the RGS (regulator of G-protein signalling) domain.","date":"2002","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11985497","citation_count":41,"is_preprint":false},{"pmid":"31364749","id":"PMC_31364749","title":"MicroRNA‑126‑3p inhibits the proliferation, migration, invasion, and angiogenesis of triple‑negative breast cancer cells by targeting RGS3.","date":"2019","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/31364749","citation_count":39,"is_preprint":false},{"pmid":"20347994","id":"PMC_20347994","title":"14-3-3 protein interacts with and affects the structure of RGS domain of regulator of G protein signaling 3 (RGS3).","date":"2010","source":"Journal of structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/20347994","citation_count":36,"is_preprint":false},{"pmid":"11897687","id":"PMC_11897687","title":"Regulation of RGS3 and RGS10 palmitoylation by GnRH.","date":"2002","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11897687","citation_count":34,"is_preprint":false},{"pmid":"26416661","id":"PMC_26416661","title":"Elevated microRNA-25 inhibits cell apoptosis in lung cancer by targeting RGS3.","date":"2015","source":"In vitro cellular & developmental biology. Animal","url":"https://pubmed.ncbi.nlm.nih.gov/26416661","citation_count":29,"is_preprint":false},{"pmid":"12036301","id":"PMC_12036301","title":"Additional 5' exons in the RGS3 locus generate multiple mRNA transcripts, one of which accounts for the origin of human PDZ-RGS3.","date":"2002","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/12036301","citation_count":28,"is_preprint":false},{"pmid":"22027839","id":"PMC_22027839","title":"Structural basis for the 14-3-3 protein-dependent inhibition of the regulator of G protein signaling 3 (RGS3) function.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22027839","citation_count":27,"is_preprint":false},{"pmid":"20629178","id":"PMC_20629178","title":"Essential role of PDZ-RGS3 in the maintenance of neural progenitor cells.","date":"2010","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/20629178","citation_count":24,"is_preprint":false},{"pmid":"15096211","id":"PMC_15096211","title":"Single phosphorylation of Tyr304 in the cytoplasmic tail of ephrin B2 confers high-affinity and bifunctional binding to both the SH2 domain of Grb4 and the PDZ domain of the PDZ-RGS3 protein.","date":"2004","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15096211","citation_count":21,"is_preprint":false},{"pmid":"14550772","id":"PMC_14550772","title":"High basal expression and injury-induced down regulation of two regulator of G-protein signaling transcripts, RGS3 and RGS4 in primary sensory neurons.","date":"2003","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/14550772","citation_count":20,"is_preprint":false},{"pmid":"11330340","id":"PMC_11330340","title":"Evidence for a short form of RGS3 preferentially expressed in the human heart.","date":"2001","source":"Naunyn-Schmiedeberg's archives of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11330340","citation_count":19,"is_preprint":false},{"pmid":"12771384","id":"PMC_12771384","title":"RGS3 mediates a calcium-dependent termination of G protein signaling in sensory neurons.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12771384","citation_count":18,"is_preprint":false},{"pmid":"18287247","id":"PMC_18287247","title":"Regulation of Smad-mediated gene transcription by RGS3.","date":"2008","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18287247","citation_count":18,"is_preprint":false},{"pmid":"15935408","id":"PMC_15935408","title":"Neuronal Kir3.1/Kir3.2a channels coupled to serotonin 1A and muscarinic m2 receptors are differentially modulated by the \"short\" RGS3 isoform.","date":"2005","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15935408","citation_count":18,"is_preprint":false},{"pmid":"24077945","id":"PMC_24077945","title":"RGS3 controls T lymphocyte migration in a model of Th2-mediated airway inflammation.","date":"2013","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24077945","citation_count":14,"is_preprint":false},{"pmid":"22859293","id":"PMC_22859293","title":"Regulator of G-protein signaling 3 isoform 1 (PDZ-RGS3) enhances canonical Wnt signaling and promotes epithelial mesenchymal transition.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22859293","citation_count":14,"is_preprint":false},{"pmid":"18457830","id":"PMC_18457830","title":"Lack of receptor-selective effects of either RGS2, RGS3 or RGS4 on muscarinic M3- and gonadotropin-releasing hormone receptor-mediated signalling through G alpha q/11.","date":"2008","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18457830","citation_count":14,"is_preprint":false},{"pmid":"9344672","id":"PMC_9344672","title":"Genomic organization, 5'-flanking region, and chromosomal localization of the human RGS3 gene.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9344672","citation_count":13,"is_preprint":false},{"pmid":"36214767","id":"PMC_36214767","title":"Pseudogene UBE2MP1 derived transcript enhances in vitro cell proliferation and apoptosis resistance of hepatocellular carcinoma cells through miR-145-5p/RGS3 axis.","date":"2022","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/36214767","citation_count":12,"is_preprint":false},{"pmid":"40456746","id":"PMC_40456746","title":"RGS3 acts as a tumor promoter by facilitating the regulation of the TGF-β signaling pathway and promoting EMT in ovarian cancer.","date":"2025","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/40456746","citation_count":11,"is_preprint":false},{"pmid":"28845525","id":"PMC_28845525","title":"RGS3 inhibits TGF-β1/Smad signalling in adventitial fibroblasts.","date":"2017","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/28845525","citation_count":11,"is_preprint":false},{"pmid":"10198412","id":"PMC_10198412","title":"Modulation of renal tubular cell function by RGS3.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10198412","citation_count":11,"is_preprint":false},{"pmid":"11716781","id":"PMC_11716781","title":"A regulator of G protein signaling, RGS3, inhibits gonadotropin-releasing hormone (GnRH)-stimulated luteinizing hormone (LH) secretion.","date":"2001","source":"BMC cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11716781","citation_count":11,"is_preprint":false},{"pmid":"15488174","id":"PMC_15488174","title":"Analysis of PDZ-RGS3 function in ephrin-B reverse signaling.","date":"2004","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/15488174","citation_count":9,"is_preprint":false},{"pmid":"36318984","id":"PMC_36318984","title":"RGS3 and IL1RAPL1 missense variants implicate defective neurotransmission in early-onset inherited schizophrenias.","date":"2022","source":"Journal of psychiatry & neuroscience : JPN","url":"https://pubmed.ncbi.nlm.nih.gov/36318984","citation_count":8,"is_preprint":false},{"pmid":"39901299","id":"PMC_39901299","title":"Exosomal mir-126-3p derived from endothelial cells induces ion channel dysfunction by targeting RGS3 signaling in cardiomyocytes: a novel mechanism in Takotsubo cardiomyopathy.","date":"2025","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/39901299","citation_count":8,"is_preprint":false},{"pmid":"11034339","id":"PMC_11034339","title":"C2PA, a new protein expressed during mouse spermatogenesis.","date":"2000","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11034339","citation_count":8,"is_preprint":false},{"pmid":"16855219","id":"PMC_16855219","title":"Muscarinic modulation of Cav2.3 (R-type) calcium channels is antagonized by RGS3 and RGS3T.","date":"2006","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16855219","citation_count":4,"is_preprint":false},{"pmid":"30971721","id":"PMC_30971721","title":"A Multi-Trait Approach Identified Genetic Variants Including a Rare Mutation in RGS3 with Impact on Abnormalities of Cardiac Structure/Function.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30971721","citation_count":4,"is_preprint":false},{"pmid":"12644305","id":"PMC_12644305","title":"A Galphas mutation (D229S) differentially effects gonadotropin-releasing hormone receptor regulation by RGS10, RGS3 and RGS3T.","date":"2003","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/12644305","citation_count":3,"is_preprint":false},{"pmid":"36284438","id":"PMC_36284438","title":"Inhibition of the expression of rgs-3 alleviates propofol-induced decline in learning and memory in Caenorhabditis elegans.","date":"2022","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/36284438","citation_count":3,"is_preprint":false},{"pmid":"12210723","id":"PMC_12210723","title":"C2PA is a nuclear protein implicated in the heat shock response.","date":"2002","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12210723","citation_count":2,"is_preprint":false},{"pmid":"15488173","id":"PMC_15488173","title":"Assays of RGS3 activation and modulation.","date":"2004","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/15488173","citation_count":2,"is_preprint":false},{"pmid":"35522181","id":"PMC_35522181","title":"Exploring the expression and preliminary function of chicken regulator of G protein signalling 3 (RGS3) gene in follicular development.","date":"2022","source":"British poultry science","url":"https://pubmed.ncbi.nlm.nih.gov/35522181","citation_count":1,"is_preprint":false},{"pmid":"32864611","id":"PMC_32864611","title":"Spindle Orientation-Independent Control of Cell Fate Determination by RGS3 and KIF20A.","date":"2020","source":"Cerebral cortex communications","url":"https://pubmed.ncbi.nlm.nih.gov/32864611","citation_count":0,"is_preprint":false},{"pmid":"42002799","id":"PMC_42002799","title":"BMSCs regulate RGS3 expression in ovarian stromal cells to improve ovarian stromal fibrosis and angiogenic microenvironment in cyclophosphamide-induced premature ovarian failure.","date":"2026","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/42002799","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":27419,"output_tokens":6123,"usd":0.087051,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14846,"output_tokens":5413,"usd":0.104777,"stage2_stop_reason":"end_turn"},"total_usd":0.191828,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"A truncated C-terminal form of RGS3 (RGS3T) inhibits Gq-mediated inositol phosphate production and Gs-mediated cAMP production in intact cells, while both full-length RGS3 and RGS3T impair Gi-mediated ERK1/2 phosphorylation, demonstrating that the C-terminal RGS domain is sufficient for Gq/Gs inhibition and that both forms regulate Gi signaling.\",\n      \"method\": \"Transient transfection of BHK cells with RGS3 or RGS3T cDNA followed by inositol phosphate, cAMP, and ERK phosphorylation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assays in intact cells with defined receptor-specific readouts, single lab, multiple signaling endpoints\",\n      \"pmids\": [\"9182581\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"RGS3 binds Gq-alpha protein in vitro; recombinant RGS3-GST fusion protein bound ~5-fold more 35S-labeled Gqα than GST alone, and RGS3 expression suppressed GnRH-stimulated IP3 responses by 75% in COS-1 cells, identifying Gqα as the mechanistic target mediating GnRH desensitization.\",\n      \"method\": \"GST pulldown with 35S-met labeled Gqα; co-transfection of GnRH receptor and RGS3 in COS-1 cells with IP3 measurement\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — GST pulldown plus functional assay in intact cells, single lab, two orthogonal methods\",\n      \"pmids\": [\"9003025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"RGS3 inhibits G protein-coupled receptor signaling by translocating from the cytosol to the plasma membrane upon G protein activation; this translocation is mediated by a dual mechanism involving both the C-terminal RGS domain (which binds activated Gα11-QL constitutively) and the N-terminal domain (which translocates in response to agonist stimulation via a calcium-dependent mechanism). RGS3 co-immunoprecipitates with AlF4-activated Gα11 and, to a lesser extent, Gαi3, through its RGS domain.\",\n      \"method\": \"Co-immunoprecipitation of RGS3 with activated Gα subunits; Western blotting of cytosolic and particulate fractions; immunofluorescence microscopy; calcium ionophore experiments; deletion mutant analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (co-IP, subcellular fractionation, immunofluorescence, mutant constructs) in single rigorous study\",\n      \"pmids\": [\"9858594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RGS3 functions as a GTPase-activating protein (GAP) for Gαi (except Gαz) and Gαq subunits but not Gαs or Gα12, with Gαq GAP activity comparable to RGS4. Mutation of residues in the RGS domain analogous to those required for RGS4 Gαi GAP activity impaired RGS3 function. RGS3 also acts as a potent Gαq effector antagonist blocking PLC-β activation, an activity that distinguishes it from RGS4.\",\n      \"method\": \"In vitro GTPase assay; active-site mutagenesis; reporter gene assay (CREB); inositol phosphate production assay in intact cells\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro GTPase reconstitution combined with active-site mutagenesis and multiple functional assays\",\n      \"pmids\": [\"10999941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"RGS3 directly binds Gβ1γ2 subunits and inhibits Gβγ-mediated signaling (inositol phosphate production, Akt activation, and MAPK activation) independently of its GAP activity; inhibition requires two regions (residues 313–390 and 391–458) outside the RGS domain. RGS3 also inhibits Gβγ-mediated PLC-β activation in vitro.\",\n      \"method\": \"Co-expression of RGS3 with Gβ1γ2 in COS-7 and HEK293 cells; deletion mutant analysis; in vitro PLC-β activation assay; inositol phosphate and Akt/MAPK assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of Gβγ-PLC inhibition plus domain mapping by deletion mutagenesis plus multiple cellular signaling readouts\",\n      \"pmids\": [\"11294858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Adenoviral-mediated RGS3 gene transfer in rat pituitary gonadotropes inhibits GnRH-stimulated LH secretion in a dose-dependent manner, consistent with RGS3 acting at Gqα to suppress inositol phosphate accumulation and downstream LH release.\",\n      \"method\": \"Adenoviral transduction of rat pituitary cells; LH secretion assay; 3H-inositol phosphate accumulation assay\",\n      \"journal\": \"BMC cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct gene delivery to primary cells with defined functional readout, single lab, two endpoints\",\n      \"pmids\": [\"11716781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"RGS3 interacts with 14-3-3 protein via a single binding site at Ser264 in its N-terminal region (outside the RGS domain); the S264A mutation abolishes 14-3-3 binding without affecting Gαq binding. 14-3-3-bound RGS3 cannot interact with G proteins, so 14-3-3 acts as a negative regulator of RGS3 by sequestering it away from Gα subunits. The S264A mutant is more potent than wild-type RGS3 in inhibiting G protein signaling.\",\n      \"method\": \"Yeast two-hybrid screening; in vitro binding assays; co-immunoprecipitation; site-directed mutagenesis (S264A); signaling assays\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — yeast two-hybrid plus in vitro binding plus co-IP plus mutagenesis plus functional signaling assays in one study\",\n      \"pmids\": [\"11985497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Endogenous RGS3 specifically negatively modulates muscarinic m3 receptor (carbachol)-stimulated MAP kinase activity through Gq/11 (pertussis toxin-insensitive) in rat vascular smooth muscle cells, as demonstrated by ribozyme-mediated knockdown of RGS3 but not RGS2, RGS5, or RGS7.\",\n      \"method\": \"Synthetic ribozymes targeting RGS3 transfected into rat aorta smooth muscle cells; MAP kinase activation assay; pertussis toxin treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ribozyme knockdown with receptor-selective readout, single lab, pertussis toxin control\",\n      \"pmids\": [\"12006602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"RGS3 undergoes agonist-dependent palmitoylation: palmitic acid incorporation into RGS3 is dependent on agonist occupancy of the GnRH receptor, whereas RGS10 palmitoylation is constitutive. This ligand-regulated palmitoylation represents a novel post-translational regulatory mechanism for RGS3.\",\n      \"method\": \"Overexpression in GGH3 cells with palmitic acid incorporation assay; site-directed mutagenesis of palmitoylation site in RGS10 as comparison\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct biochemical palmitoylation assay with agonist dependence, single lab\",\n      \"pmids\": [\"11897687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"RGS3 mediates calcium-dependent rapid termination of G protein (Go) signaling in dorsal root ganglion neurons; calcium influx through voltage-gated channels directly binds to an EF-hand domain of RGS3. Deletion of the EF-hand domain abolishes both the calcium-RGS3 interaction (gel-shift assay) and the rapid desensitization of Go-mediated N-type Ca2+ channel inhibition. A naturally occurring RGS3 variant lacking the EF hand produces slower, calmodulin-dependent desensitization instead.\",\n      \"method\": \"Retroviral overexpression of RGS3 isoforms and EF-hand deletion mutants in dorsal root ganglion neurons; electrophysiological recording of N-type Ca2+ channel inhibition; gel-shift calcium-binding assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — EF-hand deletion mutagenesis combined with biochemical calcium binding assay and electrophysiological functional readout in native neurons\",\n      \"pmids\": [\"12771384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"RGS3 (short isoform RGS3s) does not interact with GPCR-Kir3 channel complexes, in contrast to RGS4. RGS3s modulates m2 receptor-coupled GIRK channels by 'collision coupling' rather than 'precoupling', reducing maximal ACh-evoked GIRK current amplitude ~45% and shifting the dose-response relation, while RGS4 precouples to the receptor complex with ~100-fold greater potency in accelerating Kir3 channel-gating kinetics.\",\n      \"method\": \"Co-immunoprecipitation of RGS constructs with GPCR-Kir3 complexes in CHO-K1 cells; deletion and chimeric RGS constructs; electrophysiological recording of GIRK channel gating kinetics\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus electrophysiology plus chimeric constructs, single lab, mechanistically informative negative result for RGS3s-GPCR interaction\",\n      \"pmids\": [\"16973624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Full-length RGS3 and its native isoform RGS3T antagonize muscarinic M2 receptor-mediated inhibition of Cav2.3 (R-type) Ca2+ channels equally effectively; the core RGS domain alone is sufficient for this activity and the extended N-terminal domain does not enhance signaling function. The N-terminal domain of RGS3 restricts its localization to the cytoplasm as shown by confocal microscopy of GFP fusion proteins.\",\n      \"method\": \"Whole-cell patch-clamp recordings in HEK293 cells expressing Cav2.3, M2R, and RGS3 deletion mutants; confocal microscopy of RGS3-EGFP fusion proteins\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — electrophysiology with deletion mutants plus direct imaging of subcellular localization, single lab\",\n      \"pmids\": [\"16855219\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"RGS3 interacts with Smad2, Smad3, and Smad4 via a region outside its RGS domain binding to the Smad MH2 domain. RGS3 overexpression inhibits TGF-β-induced Smad-mediated gene transcription by preventing Smad3-Smad4 heteromerization without affecting TGF-β-induced Smad phosphorylation, and inhibits TGF-β-induced myofibroblast differentiation.\",\n      \"method\": \"Co-immunoprecipitation of RGS3 with Smad proteins; domain mapping; reporter gene transcription assay; Smad heteromerization assay; myofibroblast differentiation assay\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus domain mapping plus multiple functional readouts, single lab\",\n      \"pmids\": [\"18287247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"14-3-3 protein binding induces structural changes in both the N-terminal region and the C-terminal RGS domain of phosphorylated RGS3, affecting the Gα-interacting portion of the RGS domain. The crystal structure of the RGS domain of RGS3 was solved at 2.3 Å resolution. The isolated RGS domain can interact with 14-3-3 in a phosphorylation-independent manner.\",\n      \"method\": \"Time-resolved tryptophan fluorescence spectroscopy with single-tryptophan mutants; X-ray crystallography of RGS domain at 2.3 Å resolution\",\n      \"journal\": \"Journal of structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure determination plus fluorescence spectroscopy with mutagenesis, single lab, two orthogonal structural methods\",\n      \"pmids\": [\"20347994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Knockout of PDZ-RGS3 in mice causes early cell cycle exit and precocious differentiation of neural progenitor cells in the developing cerebral cortex, resulting in loss of cortical neural progenitor cells and impaired production of late-born cortical neurons, phenocopying ephrin-B1 knockout, thereby placing PDZ-RGS3 downstream of ephrin-B reverse signaling in neural progenitor maintenance.\",\n      \"method\": \"Genetic knockout (PDZ-RGS3 null mice); cortical neurogenesis analysis; comparison with ephrin-B1 knockout phenotype; cell cycle analysis\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with defined cellular phenotype and epistasis placement downstream of ephrin-B reverse signaling pathway\",\n      \"pmids\": [\"20629178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The 14-3-3ζ protein forms a complex with RGS3 in which the RGS domain of RGS3 binds to the outer surface of the 14-3-3ζ dimer (outside its central channel), and this binding both sterically occludes the Gα interaction surface of the RGS domain and induces conformational changes that impair its Gα binding.\",\n      \"method\": \"Small angle X-ray scattering (SAXS); hydrogen/deuterium exchange kinetics; FRET measurements; low-resolution solution structure determination\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — SAXS structure plus H/D exchange plus FRET, three orthogonal structural/biophysical methods in single study\",\n      \"pmids\": [\"22027839\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PDZ-RGS3 (isoform 1) is upregulated by Wnt signaling, binds GSK3β, and decreases GSK3β catalytic activity toward β-catenin, thereby enhancing canonical Wnt/β-catenin signaling. PDZ-RGS3 overexpression enhances Snail1 expression and promotes epithelial-mesenchymal transition (EMT).\",\n      \"method\": \"Co-immunoprecipitation of PDZ-RGS3 with GSK3β; kinase activity assay for GSK3β toward β-catenin; β-catenin reporter assay; Wnt3a stimulation; EMT morphological and biochemical analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus kinase activity assay plus reporter assay, single lab, multiple functional endpoints\",\n      \"pmids\": [\"22859293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Endogenous RGS3 controls T cell migration in a non-redundant manner; mice with RGS domain deletion (RGS3ΔRGS) show increased T cell numbers and formation of perivascular lymphoid structures in the lung in an asthma model, with reduced T cell numbers in draining lymph nodes, demonstrating RGS3 restricts T cell migration via its G protein regulatory (RGS) domain.\",\n      \"method\": \"Generation of RGS3ΔRGS knock-in mice; experimental asthma model; T cell enumeration in lungs and draining lymph nodes; in vitro T cell migration assay with RGS3-knockdown thymoma cells\",\n      \"journal\": \"American journal of physiology. Lung cellular and molecular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — domain-specific knock-in mouse model with in vivo and in vitro evidence for T cell migration control, multiple readouts\",\n      \"pmids\": [\"24077945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RGS3, previously known only as a regulator of GPCR/G protein signaling, can also directly enhance the GTPase activity of both wild-type and mutant KRAS proteins (including KRASG12C), thereby inactivating KRAS and enabling KRASG12C inhibitor efficacy by promoting GTP hydrolysis and accumulation of the GDP-bound inactive state.\",\n      \"method\": \"GTPase activity assays with recombinant RGS3 and KRAS proteins; biochemical and cellular studies of KRAS inactivation; KRASG12C inhibitor sensitivity experiments\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of GTPase-activating activity on KRAS with multiple mutants, combined with cellular mechanistic validation\",\n      \"pmids\": [\"34618566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"RGS3 interacts with KIF20A and together they regulate the balance between proliferative and differentiative divisions of neural progenitor cells in the developing cortex independently of spindle/cleavage plane orientation, revealing a spindle orientation-independent mechanism of cell fate determination.\",\n      \"method\": \"Loss-of-function genetic experiments in mice (RGS3 and KIF20A inactivation); spindle orientation measurement; neural progenitor cell fate analysis\",\n      \"journal\": \"Cerebral cortex communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined cellular phenotype and epistasis between RGS3 and KIF20A, single lab\",\n      \"pmids\": [\"32864611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Single phosphorylation of Tyr304 on ephrin-B2 enables bifunctional binding to both the SH2 domain of Grb4 and the PDZ domain of PDZ-RGS3 simultaneously, forming a three-component molecular complex, as determined by NMR HSQC experiments and binding assays.\",\n      \"method\": \"NMR (1H-15N HSQC) binding experiments; in vitro binding assays with phosphopeptides; three-component complex reconstitution\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structural validation of interaction plus reconstitution of ternary complex, single lab\",\n      \"pmids\": [\"15096211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"RGS3 directly interacts with ARID3B and facilitates phosphorylation of SMAD2/3, thereby enhancing TGF-β pathway activity and driving ovarian cancer cell proliferation and metastasis through EMT. Silencing RGS3 promotes apoptosis and inhibits tumor growth in ovarian cancer cells.\",\n      \"method\": \"Co-immunoprecipitation of RGS3 with ARID3B; SMAD2/3 phosphorylation assay; siRNA knockdown with proliferation, apoptosis, and metastasis readouts\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus phosphorylation assay plus functional knockdown, single lab\",\n      \"pmids\": [\"40456746\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RGS3 is a multi-isoform RGS family protein that functions primarily as a GTPase-activating protein (GAP) for Gαi and Gαq (but not Gαs, Gαz, or Gα12) subunits, accelerating GTP hydrolysis to terminate GPCR signaling; it also directly binds Gβγ subunits to block their effector interactions, translocates from cytosol to plasma membrane upon G protein activation via both its RGS and N-terminal domains, undergoes agonist-dependent palmitoylation and phosphorylation-dependent sequestration by 14-3-3 (which induces conformational changes in the RGS domain to sterically block Gα binding), binds calcium via an EF-hand domain to mediate rapid desensitization of Go signaling in sensory neurons, interacts with Smad2/3/4 to inhibit TGF-β transcriptional responses, and — through its PDZ-RGS3 isoform — links ephrin-B reverse signaling to neural progenitor self-renewal and modulates canonical Wnt signaling by binding and inhibiting GSK3β; additionally, RGS3 unexpectedly enhances GTPase activity of both wild-type and mutant KRAS, revealing a non-GPCR substrate.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RGS3 is a multi-isoform regulator of G protein signaling that terminates GPCR cascades by acting as a GTPase-activating protein (GAP) for Gαi (excluding Gαz) and Gαq, accelerating GTP hydrolysis, while sparing Gαs and Gα12 [#3]. Beyond its catalytic GAP function, RGS3 antagonizes Gαq-driven PLC-β activation as an effector antagonist [#3] and independently binds Gβ1γ2 through regions outside the RGS domain to block Gβγ-mediated inositol phosphate, Akt, and MAPK signaling [#4]. RGS3 controls signaling at endogenous receptors, negatively modulating Gq/11-coupled muscarinic m3 responses in vascular smooth muscle [#7] and Gq-coupled GnRH receptor desensitization that suppresses LH secretion [#1, #5]. Its activity is spatially and post-translationally tuned: it translocates from cytosol to plasma membrane upon G protein activation via both RGS and N-terminal domains [#2], undergoes agonist-dependent palmitoylation [#8], and is sequestered by 14-3-3 binding at Ser264, which both sterically occludes and conformationally distorts the Gα-interaction surface of the RGS domain [#6, #13, #15]. In sensory neurons, an EF-hand-containing isoform binds calcium entering through voltage-gated channels to drive rapid, calcium-dependent desensitization of Go-mediated N-type Ca2+ channel inhibition [#9]. RGS3 also operates outside canonical G protein biology: it binds Smad2/3/4 to block Smad heteromerization and inhibit TGF-β transcription [#12], and through its PDZ-RGS3 isoform links phospho-ephrin-B reverse signaling to neural progenitor self-renewal [#14, #20] and enhances canonical Wnt/β-catenin signaling by binding and inhibiting GSK3β [#16]. Most unexpectedly, RGS3 directly enhances GTPase activity of wild-type and mutant KRAS, including KRASG12C, promoting its inactive GDP-bound state [#18].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established the founding question of which G protein classes RGS3 acts on, showing isoform-specific suppression of Gq, Gs, and Gi signaling and that the C-terminal RGS domain carries the inhibitory function.\",\n      \"evidence\": \"Transfection of RGS3/RGS3T into BHK and COS-1 cells with IP, cAMP, ERK, and IP3 readouts plus GST pulldown of Gqα\",\n      \"pmids\": [\"9182581\", \"9003025\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cellular assays did not distinguish GAP catalysis from effector antagonism\", \"No in vitro GTPase reconstitution at this stage\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Resolved how RGS3 reaches its target, demonstrating activation-dependent cytosol-to-membrane translocation driven by both the RGS and N-terminal domains.\",\n      \"evidence\": \"Co-IP with AlF4-activated Gα subunits, subcellular fractionation, immunofluorescence, and deletion mutants\",\n      \"pmids\": [\"9858594\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Calcium-dependent N-terminal translocation mechanism not molecularly defined here\", \"Endogenous translocation dynamics not measured\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defined RGS3 biochemically as a bona fide GAP for Gαi/Gαq with active-site residues homologous to RGS4, and uncovered a distinct Gαq effector-antagonist activity.\",\n      \"evidence\": \"In vitro GTPase assays, active-site mutagenesis, CREB reporter, and IP production assays\",\n      \"pmids\": [\"10999941\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of effector antagonism not resolved\", \"Selectivity rules against Gαz/Gαs/Gα12 not mechanistically explained\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Extended RGS3 function beyond GAP activity by showing direct Gβγ binding and inhibition of Gβγ effector signaling through domains outside the RGS module.\",\n      \"evidence\": \"Co-expression with Gβ1γ2 in COS-7/HEK293, deletion mapping, in vitro PLC-β assay, and Akt/MAPK readouts\",\n      \"pmids\": [\"11294858\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the RGS3-Gβγ complex unknown\", \"Physiological contribution of Gβγ inhibition versus GAP activity not dissected\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identified post-translational and regulatory control of RGS3 — 14-3-3 sequestration at Ser264 and agonist-dependent palmitoylation — and confirmed non-redundant control of endogenous Gq/11 muscarinic signaling.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro binding, co-IP, S264A mutagenesis, palmitate incorporation assays, and ribozyme knockdown in vascular smooth muscle\",\n      \"pmids\": [\"11985497\", \"11897687\", \"12006602\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase responsible for Ser264 phosphorylation not identified\", \"Palmitoylation site and enzyme not mapped\", \"Functional interplay between palmitoylation and 14-3-3 sequestration unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Revealed a calcium-sensing function: an EF-hand isoform of RGS3 binds calcium entering through voltage-gated channels to mediate rapid feedback desensitization of Go signaling in neurons.\",\n      \"evidence\": \"Retroviral isoform/EF-hand-deletion expression in DRG neurons, electrophysiology of N-type Ca2+ channels, and gel-shift calcium binding\",\n      \"pmids\": [\"12771384\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural detail of EF-hand calcium coordination not determined\", \"Whether EF-hand isoform contributes to other GPCR pathways unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Mechanistically detailed PDZ-RGS3 recruitment to ephrin-B reverse signaling, showing a single ephrin-B2 phosphotyrosine enables simultaneous Grb4 and PDZ-RGS3 binding.\",\n      \"evidence\": \"NMR HSQC binding experiments, phosphopeptide binding assays, and three-component complex reconstitution\",\n      \"pmids\": [\"15096211\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream signaling output of the ternary complex not defined here\", \"In vivo relevance established only later\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Refined isoform/domain logic in channel modulation, showing the short RGS3 isoform regulates GIRK channels by collision rather than precoupling and that the N-terminal domain restricts cytoplasmic localization.\",\n      \"evidence\": \"Co-IP and electrophysiology of GPCR-Kir3/Cav2.3 complexes in CHO-K1/HEK293 with chimeric and deletion constructs and EGFP imaging\",\n      \"pmids\": [\"16973624\", \"16855219\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Quantitative kinetic comparison limited to specific channel/receptor pairs\", \"Structural basis for collision versus precoupling not established\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Connected RGS3 to TGF-β signaling, demonstrating a non-RGS region binds the Smad MH2 domain to block Smad3-Smad4 heteromerization and inhibit transcription independent of receptor phosphorylation.\",\n      \"evidence\": \"Co-IP, domain mapping, Smad reporter and heteromerization assays, and myofibroblast differentiation assay\",\n      \"pmids\": [\"18287247\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab finding without reciprocal in vivo validation\", \"Reconciliation with later report of RGS3 enhancing SMAD2/3 phosphorylation unaddressed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Provided structural mechanism for 14-3-3 inhibition and an in vivo role for PDZ-RGS3, solving the RGS domain crystal structure and showing 14-3-3 binding distorts the Gα-interaction surface, while PDZ-RGS3 knockout phenocopies ephrin-B1 loss in cortical neurogenesis.\",\n      \"evidence\": \"X-ray crystallography at 2.3 Å, time-resolved tryptophan fluorescence with single-Trp mutants, and PDZ-RGS3 knockout mouse neurogenesis analysis\",\n      \"pmids\": [\"20347994\", \"20629178\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length RGS3 structure not solved\", \"Molecular signaling linking PDZ-RGS3 to progenitor cell cycle not fully defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Completed the structural model of 14-3-3 regulation, showing the RGS domain docks on the outer surface of the 14-3-3ζ dimer to both occlude and conformationally impair Gα binding.\",\n      \"evidence\": \"SAXS solution structure, H/D exchange kinetics, and FRET\",\n      \"pmids\": [\"22027839\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of the complex not obtained\", \"Cellular stoichiometry of 14-3-3-RGS3 regulation unmeasured\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Linked PDZ-RGS3 to canonical Wnt signaling and EMT, showing Wnt-induced PDZ-RGS3 binds and inhibits GSK3β to stabilize β-catenin and promote Snail1-driven EMT.\",\n      \"evidence\": \"Co-IP, GSK3β kinase activity assay, β-catenin reporter, Wnt3a stimulation, and EMT analysis\",\n      \"pmids\": [\"22859293\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study without in vivo confirmation\", \"Mechanism of GSK3β inhibition (direct versus complex-mediated) not resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrated a non-redundant in vivo immune function, with RGS-domain deletion increasing T cell accumulation in lung and altering migration, establishing RGS3's GAP function in restricting T cell trafficking.\",\n      \"evidence\": \"RGS3ΔRGS knock-in mice in an asthma model, T cell enumeration, and in vitro migration with RGS3-knockdown thymoma cells\",\n      \"pmids\": [\"24077945\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific chemokine receptors/Gα targets in T cells not identified\", \"Cell-intrinsic versus extrinsic effects not fully separated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified a spindle-orientation-independent mode of progenitor fate control, with RGS3 partnering KIF20A to balance proliferative versus differentiative divisions.\",\n      \"evidence\": \"Loss-of-function genetics in mice, spindle orientation measurement, and progenitor fate analysis\",\n      \"pmids\": [\"32864611\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Biochemical nature of the RGS3-KIF20A interaction undefined\", \"Molecular pathway downstream of the pairing unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Overturned the GPCR-exclusive view of RGS3 by showing it directly acts as a GAP for KRAS, including KRASG12C, promoting GDP-bound inactivation and enabling inhibitor efficacy.\",\n      \"evidence\": \"In vitro GTPase assays with recombinant RGS3 and KRAS mutants plus cellular KRASG12C inhibitor sensitivity experiments\",\n      \"pmids\": [\"34618566\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of RGS3 engagement of KRAS not determined\", \"Selectivity over other small GTPases unexplored\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Implicated RGS3 in ovarian cancer, showing it binds ARID3B and promotes SMAD2/3 phosphorylation to drive TGF-β-dependent proliferation and metastasis.\",\n      \"evidence\": \"Co-IP with ARID3B, SMAD2/3 phosphorylation assays, and siRNA knockdown with proliferation, apoptosis, and metastasis readouts\",\n      \"pmids\": [\"40456746\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab finding without reciprocal validation\", \"Apparent contradiction with earlier inhibition of Smad signaling (#12) not reconciled\", \"Direct ARID3B-RGS3 binding interface unmapped\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how RGS3's diverse activities — GAP toward Gα and KRAS, Gβγ binding, Smad and GSK3β regulation — are partitioned across its isoforms and integrated in a single cell context.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified isoform-resolved map of which domains/isoforms execute each function\", \"Opposite effects on TGF-β/Smad signaling across studies unreconciled\", \"No full-length structure to relate domains spatially\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 4, 18]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [3, 18]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"GO:0140299\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 11]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 4, 7]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [14, 19, 20]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [17]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [18, 21]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"GNAQ\", \"GNAI3\", \"GNB1\", \"YWHAZ\", \"SMAD3\", \"SMAD4\", \"GSK3B\", \"KRAS\"],\n    \"other_free_text\": []\n  }\n}\n```","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}